• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Brainsway

Former Dynatronics CEO to take corner office at BrainsWay

November 26, 2019 By Sean Whooley

Neuromodulation therapy developer BrainsWay (NSDQ:BWAY) announced that it appointed former Dynatronics CEO Christopher von Jako as president and CEO. The company’s board of directors said von Jako, who will assume the role in January 2020, will be central to Brainsway’s strategic transition to U.S.-based leadership. Prior to his role as CEO of Dynatronics, von Jako served […]

Filed Under: Business/Financial News, Neuromodulation/Neurostimulation Tagged With: Brainsway, Personnel Moves

These 10 medtech companies care a lot about research

November 1, 2019 By Danielle Kirsh

These 10 medical device companies spent the largest portion of their budgets on research and development. Here’s a look at what they produced. Each year, Medical Design & Outsourcing compiles a list of the top 100 medical device companies across the globe and ranks the companies based on annual revenue for the most recent fiscal year. We […]

Filed Under: Business/Financial News Tagged With: AtriCure Inc., Big 100, Brainsway, conformis, Dexcom, Edwards Lifesciences, Glaukos, Inspire Medical Systems Inc., Insulet, Ra Medical, TransEnterix

BrainsWay touts results of dTMS study for depression

July 18, 2019 By Nancy Crotti

BrainsWay (NSDQ:BWAY) said today that a study shows that deep transcranial magnetic stimulation (dTMS) plus standard medication was significantly more effective at reducing depression levels among major depressive disorder (MDD) patients than standard medication alone. Researchers at the Psychiatric Hospital Sveti Ivan in Croatia conducted the 228-patient randomized controlled study independent of industry support. The […]

Filed Under: Blog, Clinical Trials, Featured, Neuromodulation/Neurostimulation, News Well, Research & Development Tagged With: Brainsway

Brainsway prices downsized $28m IPO

April 17, 2019 By Brad Perriello

Brainsway yesterday priced its initial public offering in the U.S. slightly below the terms it set earlier this month. The Jerusalem-based company, which is already publicly traded in Israel, said April 3 that it planned to float 2.5 million American Depository shares at roughly $11.94 apiece. Each ADS is would represent two ordinary shares, slated […]

Filed Under: Featured, Funding Roundup, Initial Public Offering (IPO), Neuromodulation/Neurostimulation, Wall Street Beat Tagged With: Brainsway

Brainsway sets terms for $30m IPO

April 5, 2019 By Brad Perriello

Brainsway this week set the terms on its forthcoming initial public offering in the U.S., saying it hopes to raise nearly $30 million. The Jerusalem-based company, which developed a transcranial magnetic stimulation device to treat psychological disorders, said it plans to float 2.5 million American Depository shares at roughly $11.94 apiece. Each ADS is slated […]

Filed Under: Featured, Funding Roundup, Neuromodulation/Neurostimulation, Wall Street Beat Tagged With: Brainsway

Brainsway registers for $30m IPO

January 16, 2019 By Fink Densford

Brainsway has registered for an upcoming initial public offering, looking to bring in $30 million to support its transcranial magnetic stimulation tech, according to a recently posed SEC filing. The Israel-based company said that it plans to list on the Nasdaq Global Market under the symbol “BWAY,” according to the filing. Brainsway develops and supports […]

Filed Under: Business/Financial News, Neurological Tagged With: Brainsway

FDA chooses 8 medtech companies for opioid crisis challenge

December 3, 2018 By Nancy Crotti

The FDA has selected eight medtech companies to develop devices to help reduce the country’s opioid abuse crisis. More than 250 companies submitted entries to the FDA Innovation Challenge: Devices to Prevent and Treat Opioid Use Disorder, announced in May. Those selected include Masimo Corp. and deep-brain-stimulation company Brainsway Ltd. The companies will be expected to […]

Filed Under: Food & Drug Administration (FDA), Implants, Pain Management, Research & Development Tagged With: algometRx, Avanos Medical (formerly Halyard Health), Brainsway, cognifisense, ipill, Masimo, milliman, ThermoTek

BrainsWay wins ‘historic milestone’ clearance to treat OCD

August 22, 2018 By Nancy Crotti

BrainsWay said it has won de novo clearance from the FDA for its deep transcranial magnetic stimulation (Deep TMS) system for treatment of obsessive-compulsive disorder (OCD) in adults. The clearance marks the second indication granted for BrainsWay Deep TMS, and the first noninvasive medical device clearance for the treatment of OCD. The FDA  cleared the device […]

Filed Under: Food & Drug Administration (FDA), Neuromodulation/Neurostimulation Tagged With: Brainsway, De Novo Clearance, FDA

Brainsway wins FDA nod for OCD-treating TMS system

August 17, 2018 By Fink Densford

The FDA today said it granted de novo approval for Brainsway‘s deep transcranial magnetic stimulation system, now indicated for treating obsessive compulsive disorder. The TMS system uses magnetic fields to simulate nerves in the brain, and has been shown to reduce the severity of OCD in patients. A 100-patient randomized, multi-center study of the device […]

Filed Under: Neurological, Neuromodulation/Neurostimulation, Regulatory/Compliance Tagged With: Brainsway

7 medtech stories we missed this week: May 11, 2018

May 11, 2018 By Danielle Kirsh

From ReShape submitting an approval application to Health Canada to Conavi receiving FDA clearance, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. ReShape submits for Health Canada approval of ReShape balloon ReShape announced in a May 10 press release that it has submitted an application to the Medical Devices Bureau […]

Filed Under: 510(k), Cardiovascular, Digital Health, Food & Drug Administration (FDA), Hospital Care, Imaging, Neurological, Patient Monitoring, Regulatory/Compliance Tagged With: Brainsway, Conavi, Exact Imaging, innovativehealth, MedTech, PeraHealth, qtmedical, ReShape Lifesciences

Transcranial magnetic stim dev Brainsway raises $9m

December 12, 2017 By Fink Densford

Transcranial magnetic stimulation device developer Brainsway has raised $8.5 million, according to a report from Globes Israel. The round was joined by The Phoenix Holdings and IBI Investment House, which has an existing 8% stake in the company. Israel-based Brainsway is developing magnetic stimulation helmets for treating neurological and psychiatric disorders, according to Globes Israel. […]

Filed Under: Business/Financial News, Neurological Tagged With: Brainsway

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS

  1. themes/genesis/config/layouts.php
  2. themes/genesis/config/requirements.php
  3. themes/genesis/footer.php
  4. themes/genesis/functions.php
  5. themes/genesis/header.php
  6. themes/genesis/lib/admin/term-meta.php
  7. themes/genesis/lib/admin/user-meta.php
  8. themes/genesis/lib/classes/class-genesis-requirements-views.php
  9. themes/genesis/lib/classes/class-genesis-script-loader.php
  10. themes/genesis/lib/classes/class-genesis-search-form.php
  11. themes/genesis/lib/css/load-styles.php
  12. themes/genesis/lib/framework.php
  13. themes/genesis/lib/functions/breadcrumb.php
  14. themes/genesis/lib/functions/compat.php
  15. themes/genesis/lib/functions/deprecated.php
  16. themes/genesis/lib/functions/feed.php
  17. themes/genesis/lib/functions/formatting.php
  18. themes/genesis/lib/functions/general.php
  19. themes/genesis/lib/functions/head.php
  20. themes/genesis/lib/functions/image.php
  21. themes/genesis/lib/functions/layout.php
  22. themes/genesis/lib/functions/markup.php
  23. themes/genesis/lib/functions/menu.php
  24. themes/genesis/lib/functions/open-graph.php
  25. themes/genesis/lib/functions/options.php
  26. themes/genesis/lib/functions/post-meta.php
  27. themes/genesis/lib/functions/requirements.php
  28. themes/genesis/lib/functions/rest.php
  29. themes/genesis/lib/functions/seo.php
  30. themes/genesis/lib/functions/toolbar.php
  31. themes/genesis/lib/functions/upgrade.php
  32. themes/genesis/lib/functions/version.php
  33. themes/genesis/lib/functions/widgetize.php
  34. themes/genesis/lib/init.php
  35. themes/genesis/lib/js/load-scripts.php
  36. themes/genesis/lib/shortcodes/footer.php
  37. themes/genesis/lib/shortcodes/post.php
  38. themes/genesis/lib/structure/archive.php
  39. themes/genesis/lib/structure/comments.php
  40. themes/genesis/lib/structure/footer.php
  41. themes/genesis/lib/structure/header.php
  42. themes/genesis/lib/structure/layout.php
  43. themes/genesis/lib/structure/loops.php
  44. themes/genesis/lib/structure/menu.php
  45. themes/genesis/lib/structure/post.php
  46. themes/genesis/lib/structure/sidebar.php
  47. themes/genesis/lib/widgets/featured-page-widget.php
  48. themes/genesis/lib/widgets/featured-post-widget.php
  49. themes/genesis/lib/widgets/user-profile-widget.php
  50. themes/genesis/lib/widgets/widgets.php
  51. themes/genesis/searchform.php
  52. themes/genesis/sidebar.php
  53. themes/news-pro/functions.php
  54. themes/news-pro/lib/customize.php
  55. themes/news-pro/lib/helper-functions.php
  56. themes/news-pro/lib/output.php
  57. themes/news-pro/lib/theme-defaults.php
  58. themes/news-pro/lib/woocommerce/woocommerce-notice.php
  59. themes/news-pro/lib/woocommerce/woocommerce-output.php
  60. themes/news-pro/lib/woocommerce/woocommerce-setup.php